In TILs from renal cell carcinoma patients, studies have found that GSH levels in exhausted CD8+ T cells are approximately 40% lower than those in normal CD8+ T cells, while ROS levels are about 2.5 times higher, subjecting T-cell survival and function to double blows (160, 161). This evidence concerns the gene CD8A and renal cell carcinoma.